Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis

Immunological Investigations

Volumn 37, Issue 8, 2008, Pages 849-857

  Habib, H M ^a   Mosaad, Y M ^b   Youssef, H M ^a  

^a Al Ahsa Hospital   (Saudi Arabia)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anti CCP antibodies; Erosions; JIA; Subtypes

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; POLYARTHRITIS; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES; ANTIGENS, NUCLEAR; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; EGYPT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PEPTIDES, CYCLIC; PREVALENCE; RHEUMATOID FACTOR;

EID: 57349120581     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130802438057     Document Type: Article

References (27)

1. Avcin, T., Cimaz, R., Falcini, F., et al. (2002). Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann. Rheum. Dis. 61:608-611.
2. Dewint, P., Hoffman, I.E.A., Rogge, S., et al. (2006). Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. J. Rheumatol. 45(2):204-208.
3. el-Gamal, Y., Hossny, E., Mabrouk, R., el-Gamasey, T. (1995). Antiperinuclear factor in the diagnosis of juvenile rheumatoid arthritis. Pediatr. Allergy Immunol. 6:165-169.
4. Ferucci, E.D., Majka, D.S., Parrish, L.A., et al. (2005). Antibodies against Cyclic Citrullinated Peptide are associated with HLA-DR4 in simplex and multiplex polyarticularonset juvenile rheumatoid arthritis. Arthritis Rheum. 52(1): 239-246.
5. Gabay, C., Prieur, A.M., Meyer, O. (1993). Occurrence of antiperinuclear, antikeratin and anti-RA33 antibodies in juvenile chronic arthritis. Ann. Rheum. Dis. 552:78-79.
6. Goldbach-Mansky, R., Lee, J., McCoy, A., et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2000;43:236-233.
7. Hromadnikova, I., Stechova, K., Pavla, V., et al. (2002). Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 35:397-401.
8. Hromandnikova, I., Vavrinocova, P., Stechova, K., Hridelova, D. (2001). Anti-keratin antibodies in patients with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 19:470-473.
9. Kasapçopur, Ö., Altun, S., Aslan, M., et al. (2004). Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann. Rheum. Dis. 63:1687-1689.
10. Kroot, E.J.J.A., de Jong, B.A.W., van Leeuwen, M.A., et al. (2000). The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43:1831-1835.
11. Kwok, J.S., Hui, K.H., Lee, T.L., et al. (2005). Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand. J. Rheumatol. 34(5): 359-366.
12. Lawrence III, J.M., Moore, T.L., Osborn, T.G., Nesher, G., Madson, K.L., Kinsella, M.B. (1993). Autoantibody studies in juvenile rheumatoid arthritis. Semin. Arthritis Rheum. 1993; 22:265-274.
13. Low, J.M., Chauhan, A.K., Kietz, D.A., Daud, U., Pepmueller, P.H., Moore, T.L. (2004). Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J. Rheumatol. 31(9):1829-1833.
14. Mediwake, R., Isenberg, D.A., Schellekens, G.A., van Venrooij, W.J. (2001). Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum. Dis. 60:67-8.
15. Petty, R.E., Southwood, T., Baum, J., et al. (1998). Revision of the proposal classification criteria for juvenile idiopathic arthritis; 1997. J. Rheumatol. 25:1991-1994.
16. Schellekens, G.A., de Jong, B.A.W., van den Hoogen, F.H.J., van de Putte, L.B.A., van Venrooij, W.J. (1998). Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101:273-81.
17. Schellekens G.A., Visser, H., De Jong, B.A.W., et al. (2000). The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43:155-63.
18. Schneider, R., Passo, M.H. (2002). Juvenile rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 28:509-30.
19. Serra, C.R.B., Rodrigues, S.H., Sztajnbok, F.R., Silva, N.P., Andrade, L.E.C. (1999). Antiperinuclear factor and antibodies to stratum corneum of rat esophagus in juvenile idiopathic arthritis. J. Pediatr. 134:507-9.
20. Symmons, D.P.M., Jones, M., Osbborne, J., Stills, J., Southwood, T.R., Woo, P. (1996). Pediatric rheumatology in the United Kingdom: data from the British pediatric rheumatology group national diagnostic register. J. Rheumatol. 23:1975-1980.
21. van Gaalen, F.A., Linn-Rasker, S.P., van Venrooij, W.J., et al. (2004). Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 50:709-715.
22. van Gaalen, F.A., Van Aken, J., Huizinga, T.W., et al. (2004). Association between HLA Class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50(7):2113-2121.
23. van Jaarsveld, C.H.M., ter Borg, E.J., Jacobs, J.W.G., et al. (1999) The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin. Exp. Rheumatol. 17:689-697.
24. van Rossum, M., van Soesbergen, R., de Kort, S., et al. (2003). Anti-cyclic citrullinated peptide antibodies in children with juvenile idiopathic arthritis. J. Rheumatol. 30:825-828.
25. van Venrooij, W.J., Hazes, J.M., Visser, H. (2002). Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth. J. Med. 60:383-388.
26. Vincent, C., de Keyser, F., Masson-Bessiére, C., Sebbag, M., Veys, E.M., Serre, G. (1999). Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann. Rheum. Dis. 58:42-48.
27. Woo, P., Wedderburn, L.R. (1998). Juvenile chronic arthritis. Lancet 351:969-973.